← Back to Analyst Consensus 
OLMA Buy
Olema Pharmaceuticals, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 14, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Aug 13, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Aug 11, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 11, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 27, 2026 | Wolfe Research | initiate | — → Peer Perform | — | 54% |
| Mar 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| Mar 18, 2026 | Goldman Sachs | maintain | Buy → Buy | — | 54% |
| Mar 17, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Mar 17, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 9, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Feb 11, 2026 | Stifel | initiate | — → Buy | $48 | 53% |
| Jan 7, 2026 | UBS | initiate | — → Buy | $45 | 54% |
| Jan 7, 2026 | Piper Sandler | initiate | — → Overweight | $0 | 54% |
| Dec 12, 2025 | Citigroup | maintain | Buy → Buy | $60 | 54% |
| Dec 11, 2025 | Oppenheimer | maintain | Outperform → Outperform | $48 | 52% |
| Dec 11, 2025 | Goldman Sachs | maintain | Buy → Buy | $38 | 54% |
| Dec 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $45 | 44% |
| Nov 21, 2025 | Goldman Sachs | maintain | Buy → Buy | $26 | 54% |
| Nov 18, 2025 | Oppenheimer | maintain | Outperform → Outperform | $45 | 52% |
| Nov 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $36 | 44% |
| Nov 18, 2025 | JP Morgan | maintain | Overweight → Overweight | $32 | 55% |
| Oct 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
| Oct 8, 2025 | Guggenheim | initiate | — → Buy | $20 | 52% |
| Sep 3, 2025 | Oppenheimer | maintain | Outperform → Outperform | $22 | 52% |
| Aug 14, 2025 | JP Morgan | maintain | Overweight → Overweight | $29 | 55% |
| Aug 12, 2025 | Citigroup | maintain | Buy → Buy | $21 | 54% |
| May 14, 2025 | Goldman Sachs | maintain | Buy → Buy | $18 | 54% |
| May 14, 2025 | Oppenheimer | maintain | Outperform → Outperform | $22 | 52% |
| Apr 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Mar 28, 2025 | JP Morgan | maintain | Overweight → Overweight | $28 | 55% |
| Mar 19, 2025 | Oppenheimer | reiterate | Outperform → Outperform | $25 | 52% |
| Mar 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Mar 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Mar 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Dec 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $0 | 44% |
| Dec 11, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Oct 24, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Aug 8, 2024 | JP Morgan | maintain | Overweight → Overweight | $31 | 55% |
| Aug 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| Aug 7, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $30 | 52% |
| Jun 4, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $30 | 44% |
| May 9, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $28 | 44% |
| Apr 2, 2024 | Goldman Sachs | initiate | — → Buy | $24 | 54% |
| Mar 12, 2024 | Oppenheimer | reiterate | Outperform → Outperform | $21 | 52% |
| Mar 12, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $25 | 44% |
| Jan 30, 2024 | Citigroup | initiate | — → Buy | $20 | 54% |
| Oct 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $28 | 44% |
Price Target Trend
Apr 25, 2026 Latest: $36.5 Oct 24, 2026
EPS Estimates
+1q $-0.66
Lo: $-0.73 Hi: $-0.52
9 analysts ▲1
0y $-2.38
Lo: $-2.69 Hi: $-1.92
9 analysts ▲1
0q $-0.63
Lo: $-0.73 Hi: $-0.50
9 analysts ▲1
+1y $-2.64
Lo: $-3.09 Hi: $-2.04
9 analysts ▲1
Cross-Platform Signals
No cross-platform signals in the last 90 days